Mustang Bio Inc (MBIO)
0.2283
-0.01
(-3.14%)
USD |
NASDAQ |
Nov 15, 16:00
0.212
-0.02
(-7.14%)
After-Hours: 20:00
Mustang Bio Free Cash Flow (Quarterly): -1.757M for Sept. 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -1.757M |
June 30, 2024 | -2.335M |
March 31, 2024 | -5.321M |
December 31, 2023 | -7.284M |
September 30, 2023 | -12.07M |
June 30, 2023 | -12.43M |
March 31, 2023 | -17.81M |
December 31, 2022 | -15.71M |
September 30, 2022 | -16.93M |
June 30, 2022 | -17.88M |
March 31, 2022 | -17.62M |
December 31, 2021 | -16.18M |
September 30, 2021 | -12.28M |
June 30, 2021 | -14.54M |
March 31, 2021 | -16.04M |
December 31, 2020 | -10.94M |
September 30, 2020 | -11.73M |
June 30, 2020 | -8.382M |
Date | Value |
---|---|
March 31, 2020 | -10.68M |
December 31, 2019 | -10.88M |
September 30, 2019 | -9.729M |
June 30, 2019 | -9.684M |
March 31, 2019 | -6.982M |
December 31, 2018 | -6.827M |
September 30, 2018 | -5.948M |
June 30, 2018 | -8.098M |
March 31, 2018 | -6.316M |
December 31, 2017 | -5.569M |
September 30, 2017 | -6.593M |
June 30, 2017 | -1.174M |
March 31, 2017 | -2.411M |
December 31, 2016 | -2.263M |
September 30, 2016 | -0.565M |
June 30, 2016 | -0.72M |
March 31, 2016 | -0.581M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-17.88M
Minimum
Jun 2022
-1.757M
Maximum
Sep 2024
-11.94M
Average
-12.18M
Median
Free Cash Flow (Quarterly) Benchmarks
Fortress Biotech Inc | -21.84M |
AIM ImmunoTech Inc | -3.237M |
Perspective Therapeutics Inc | -9.917M |
Protalix BioTherapeutics Inc | -3.782M |
Armata Pharmaceuticals Inc | -11.54M |